Colorectal Cancer (CRC) Unknown Status Phase 3 Trials for Leucovorin (DB00650)

Back to Colorectal Cancer (CRC)

Also known as: Malignant Neoplasm of Colorectum / CRC, Colorectal Cancer / Colorectal Cancer / Cancer, Colorectal / CRC (Colorectal Cancer) / Colorectal, Cancer / Colo-rectal Cancer / Colorectal Cancers / A. Colorectal Cancer / Cancer Colorectal / Gastrointestinal Cancers - Colorectal / CRC / CRCS / Malignant colorectal neoplasm / Malignant neoplasm of cecum and/or colon and/or rectum / Malignant neoplasm of caecum and/or colon and/or rectum / Malignant neoplasm of cecum and/or colon and/or rectum (disorder) / Malignant neoplasm of large intestine / Malignant tumor of large intestine / Malignant tumour of large intestine / Malignant neoplasm of large intestine (disorder) / Malignant neoplasm of colon, unspecified / Malignant large intestinal neoplasm NOS / Cancer of large intestine / Malignant neoplasm of large intestine, NOS / Cancer of large bowel / CA - Cancer of large bowel / Colorectal neoplasms malignant / Malignant neoplasm of colon and/or rectum (disorder) / Large intestine carcinoma / Colorectal carcinoma / Colorectal cancer NOS

Indication	Status	Phase
DBCOND0031867 (Colorectal Cancer (CRC))	Unknown Status	3

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT02965248	Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Versus no HIPEC in Locally Advanced Colorectal Cancer (APEC Study)	Treatment	Capecitabine (DB01101) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT04338191	mFOLFOXIRI Versus mFOLFOX6 as Adjuvant Chemotherapy for Locally Advanced Colorectal Cancer	Treatment	Fluorouracil (DB00544) Irinotecan (DB00762) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT00002793	Chemotherapy Via an Implantable Pump Compared With a Subcutaneous Port for Unresectable Liver Metastases in Patients With Resected Colorectal Cancer	Treatment	Fluorouracil (DB00544) Leucovorin (DB00650)
NCT00797485	Bevacizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Metastatic Colorectal Cancer That Cannot Be Removed By Surgery	Treatment	Bevacizumab (DB00112) Capecitabine (DB01101) Fluorouracil (DB00544) Irinotecan (DB00762) Leucovorin (DB00650)
NCT00958737	Combination Chemotherapy for 3 Months or 6 Months in Treating Patients With Stage III Colon Cancer	Treatment	Capecitabine (DB01101) Fluorouracil (DB00544) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT00385970	A Phase III Trial Comparing UFT+PSK to UFT+LV in Stage IIB, III Colorectal Cancer	Treatment	Leucovorin (DB00650) Tegafur-uracil (DB09327)
NCT01566942	FOLFIRI or mFOLFOX6 in Adjuvant Chemotherapy in Advanced Colorectal Cancer	Treatment	Fluorouracil (DB00544) Irinotecan (DB00762) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT00482222	Combination Chemotherapy With or Without Cetuximab Before and After Surgery in Treating Patients With Resectable Liver Metastases Caused By Colorectal Cancer	Treatment	Capecitabine (DB01101) Cetuximab (DB00002) Fluorouracil (DB00544) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT00433927	5-FU, Folinic Acid and Irinotecan (FOLFIRI) Plus Cetuximab Versus FOLFIRI Plus Bevacizumab in First Line Treatment Colorectal Cancer (CRC)	Treatment	Bevacizumab (DB00112) Cetuximab (DB00002) Irinotecan (DB00762) Leucovorin (DB00650)
NCT02402972	A Multi-center Randomized Controlled Trial of Intraportal Chemotherapy Combined With Adjuvant Chemotherapy (mFOLFOX6) for Stage II and III Colon Cancer	Treatment	Floxuridine (DB00322) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT00091312	Fluorouracil and Irinotecan With or Without Leucovorin Compared With Observation in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer	Treatment	Fluorouracil (DB00544) Irinotecan (DB00762) Leucovorin (DB00650)
NCT00021281	Combination Chemotherapy With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer	Treatment	Fluorouracil (DB00544) Irinotecan (DB00762) Leucovorin (DB00650) Semaxanib (DB06436)
NCT00008281	Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer	Treatment	Fluorouracil (DB00544) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT00006479	Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer	Treatment	Fluorouracil (DB00544) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT00002893	Palliative Chemotherapy in Treating Patients With Advanced Colorectal Cancer	Treatment	Fluorouracil (DB00544) Leucovorin (DB00650) Raltitrexed (DB00293)
NCT00497107	Uracil and Tegafur/Leucovorin (UFT/LV) Versus UFT/LV+ Polysaccharide-K (PSK) for Stage IIIa/IIIb Colorectal Cancer	Treatment	Leucovorin (DB00650)
NCT00182715	Combination Chemotherapy With or Without Cetuximab as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer	Treatment	Capecitabine (DB01101) Cetuximab (DB00002) Fluorouracil (DB00544) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT00209742	Randomized Phase III Adjuvant Study for Stage III Colorectal Cancer	Treatment	Leucovorin (DB00650) Tegafur-uracil (DB09327)
NCT00002896	Radiation Therapy Plus Chemotherapy Before Surgery With or Without Chemotherapy After Surgery in Treating Patients With Rectal Cancer	Treatment	Fluorouracil (DB00544) Leucovorin (DB00650)
NCT00003063	Biological Therapy With Combination Chemotherapy in Patients With Colorectal Cancer	Treatment	Fluorouracil (DB00544) Interferon alfa (DB05258) Leucovorin (DB00650) Levamisole (DB00848)
NCT01308086	Adjuvant Therapy(3 vs. 6 Months) With the FOLFOX 4 or XELOX for Stage II or Stage III Colon Cancer	Treatment	Capecitabine (DB01101) Fluorouracil (DB00544) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT01895257	Comparing HAI-90Y (SIR-spheres)+Chemotx LV5FU2 Versus Chemotx LV5FU2 Alone to Treat Colorectal Cancer	Treatment	Fluorouracil (DB00544) Leucovorin (DB00650)
NCT04525326	Conversion Therapy of RAS/BRAF Wild-Type Right-sided Colon Cancer Patients With Initially Unresectable Liver Metastases	Treatment	Bevacizumab (DB00112) Cetuximab (DB00002) Fluorouracil (DB00544) Irinotecan (DB00762) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT00003260	Combination Chemotherapy in Treating Patients With Recurrent Metastatic Colorectal Cancer	Treatment	Fluorouracil (DB00544) Irinotecan (DB00762) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT01238094	Trial of XELIRI/FOLFIRI + Simvastatin Followed by Simvastatin Maintenance in Metastatic Colorectal Cancer	Treatment	Fluorouracil (DB00544) Irinotecan (DB00762) Leucovorin (DB00650) Simvastatin (DB00641)
NCT00002692	Intravenous Compared With Intrahepatic Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver	Treatment	Fluorouracil (DB00544) Leucovorin (DB00650)
NCT00006468	Comparing Two Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer	Treatment	Fluorouracil (DB00544) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT02785146	Adjuvant Chemotherapy Combined With Huaier Granule for Treating High-risk Stage II, Stage III Colorectal Cancer	Treatment	Fluorouracil (DB00544) Huaier (DB28085) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT00046995	Combination Chemotherapy in Treating Patients With Colon Cancer	Treatment	Carboplatin (DB00958) Fluorouracil (DB00544) Leucovorin (DB00650)
NCT04392479	TWICE-IRI: Optimization of Second-line Therapy With Aflibercept, Irinotecan (Day 1 or Day 1,3), 5-Fluorouracile and Folinic Acid in Patients With Metastatic Colorectal Cancer. A Randomized Phase III Study.	Treatment	Aflibercept (DB08885) Fluorouracil (DB00544) Irinotecan (DB00762) Leucovorin (DB00650)